Related Experiment Video
Updated: Aug 5, 2026

A Microfluidic System for Modeling Endothelial Dysfunction under Combined Physiological Pulsatile Shear Stress and Oscillatory Hyperglycemia
Published on: May 12, 2026
SARS-CoV-2 Spike Protein Exacerbates Endothelial Dysfunction and Promotes Lung Injury in Aging Type 2 Diabetes
Nur Fatin Zalikha Zailan1, Hui Yee Chee2, Eusni Rahayu Mohd Tohit1
1Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Severe COVID-19 is worsened by diabetes-associated endothelial dysfunction (ED) and SARS-CoV-2 spike protein (SP). This interaction increases inflammation and lung injury, suggesting new therapeutic targets for high-risk patients.
Area of Science:
- Cardiovascular Biology
- Infectious Diseases
- Endocrinology
Background:
- Advanced age and diabetes mellitus (DM) are key risk factors for severe COVID-19 outcomes, including acute respiratory distress syndrome (ARDS) and increased mortality.
- SARS-CoV-2 spike protein (SP) interaction with ACE2 may disrupt the renin-angiotensin system (RAS), leading to vascular dysfunction, particularly in individuals with pre-existing endothelial dysfunction (ED).
Purpose of the Study:
- To investigate the synergistic mechanisms by which SP exacerbates diabetes-associated ED and contributes to severe COVID-19 pathology.
- To identify potential biomarkers and therapeutic targets for managing severe COVID-19 in patients with type 2 diabetes mellitus (T2DM).
Main Methods:
- Utilized an in vitro co-culture model of human aortic endothelial cells (HAoECs) and ACE2-transfected human bronchial epithelial cells (BEAS-2BACE2-eGFP).
- Stimulated HAoECs with serum from healthy adults and T2DM patients, with or without SP, to assess ED markers (ROS, ICAM-1, VCM-1, permeability).
- Measured ACE2 expression and Ang II levels in BEAS-2BACE2-eGFP cells and evaluated lung injury and cytokine release in the co-culture system.
Main Results:
- T2DM serum significantly increased oxidative stress, adhesion molecule expression, and endothelial permeability in HAoECs.
- Co-exposure to T2DM serum and SP markedly reduced ACE2 expression and elevated Ang II levels in BEAS-2BACE2-eGFP cells.
- Combined T2DM serum and SP treatment exacerbated endothelial dysfunction, heightened inflammation, induced lung epithelial injury, and increased pro-inflammatory cytokine release.
Conclusions:
- Diabetes-associated ED synergizes with SARS-CoV-2 SP to aggravate vascular inflammation and lung injury, contributing to severe COVID-19.
- Adhesion molecules and pro-inflammatory cytokines are potential biomarkers for severe COVID-19 in T2DM patients.
- RAS dysregulation and endothelial activation represent promising therapeutic targets for severe COVID-19 in the context of T2DM.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Diabetes and Cancer
Coronavirus
Type I Diabetes II: Pathophysiology